New drug AN2-502998 tested in healthy people for first time
Knowledge-focused
Completed
This early-stage study tested a new oral drug called AN2-502998 in 72 healthy adults aged 18 to 55. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored side effects and drug le…
Phase: PHASE1 • Sponsor: AN2 Therapeutics, Inc • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC